New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 25, 2012
16:21 EDTMTN, CAT, MACK, RIMM, KEG, TSLAOn The Fly: Closing Wrap
Stocks on Wall Street were lower as unrest in Spain brought the difficult fiscal challenges facing Europe back into the spotlight. Stocks opened slightly higher as the market was helped in part by better than expected consumer confidence and home price data. With little else for investors to key on domestically, the averages weakened in the afternoon, as European headlines again drove concern... ECONOMIC EVENTS: Domestically, the S&P/Case-Shiller 20-city home prices index for July indicated that prices rose 1.2%, beating expectations. The consumer confidence reading for September rose to 70.3 and the FHFA home prices index for July was up 0.2%. In Europe, protesters in Spain took to the streets to voice their displeasure with further austerity measures. Also, Germany's Jorg Asmussen, an executive board member of the European Central Bank, said any additional Greek financing needs to come from EU member states and not the ECB... COMPANY NEWS: After lowering its 2015 guidance late Monday, shares of Caterpillar (CAT) were down $3.86, or 4.25%, to $87.01... Tesla Motors (TSLA) shares fell $3.00, or 9.78%, to $27.66 after the company reduced its second half of 2012 Model S delivery guidance and cut its revenue outlook for the year... MAJOR MOVERS: Among the notable gainers were Research in Motion (RIMM), up 30c, or 4.68%, to $6.60 after saying BlackBerry subscribers now total 80M during a company hosted conference, and Vail Resorts (MTN), up $4.37, or 8.29%, to $57.10 after its quarterly revenues beat expectations and its losses were not as steep as forecast. Noteworthy losers included Key Energy (KEG), down $1.02, or 12.52%, to $7.13 after lowering its Q3 expectations, and Merrimack (MACK), down $1.85, or 16.91%, to $9.09 as an IPO lockup period expired today for the shares... INDICES: The Dow lost 101.37, or 0.75%, to 13,457.55; the Nasdaq fell 43.05, or 1.36%, to 3,117.73; and the S&P 500 declined 15.30, or 1.05%, to 1,441.59.
News For CAT;TSLA;RIMM;MTN;KEG;MACK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 21, 2015
06:01 EDTMACKMerrimack price target raised to $16 from $13 at Mizuho
Subscribe for More Information
April 20, 2015
16:07 EDTMACKMerrimack announces final clinical results for MM-302 Phase 1 study
Merrimack Pharmaceuticals announced updated and final clinical results for the Phase 1 study of MM-302, a novel HER2-targeted liposomal doxorubicin, in HER2-positive metastatic breast cancer. Data described the safety and promising clinical activity of MM-302 in patients with advanced HER2-positive metastatic breast cancer. Results from the trial showed that the group of patients treated with 30 mg/m2 or more of MM-302 alone, in combination with trastuzumab or with trastuzumab and cyclophosphamide, had a median progression free survival, or mPFS, of 7.6 months and an overall response rate, or ORR, of 11%. Of note, 25 patients who had not been previously treated with anthracyclines had an mPFS of 11 months and an ORR of 24%. The most frequent adverse events occurring in greater than 20% of the population in this Phase 1 study were constipation, cough, decreased appetite, diarrhea, dyspnea, fatigue, nausea, neutropenia, stomatitis and vomiting. The most common Grade 3/4 adverse event was neutropenia observed in 8 patients. Six out of 69 patients 9% had protocol-defined asymptomatic declines in left ventricular ejection fraction, or LVEF. In 1 of the 6 patients, this was reported as a Grade 1 cardiac failure that was possibly related to study treatment. Merrimack is currently enrolling the HERMIONE study that is designed to support a potential application for accelerated approval in the U.S. and conditional marketing authorization in the E.U. The HERMIONE study is for HER2-positive, metastatic breast cancer patients who are anthracycline-naive and have not been previously treated with pertuzumab and T-DM1-containing regimens.
14:10 EDTTSLANissan: China should add incentives for electric vehicles, Automotive News says
Nissan CEO Carlos Ghosn said he was disappointed by electric vehicle sales in China and called on Beijing to intensify incentives for electric vehicles, according to Automotive News. Tesla (TSLA) also sells electric vehicles in China. Reference Link
12:53 EDTTSLANissan: China should add incentives for electric vehicles, Automotive News says
Subscribe for More Information
09:36 EDTTSLAActive equity options trading on open
Subscribe for More Information
08:21 EDTTSLATesla almost sold to Google while near bankruptcy in 2013, Bloomberg says
Subscribe for More Information
08:04 EDTTSLATesla CEO held talks to sell company to Google in 2013, Bloomberg reports
Bloomberg cites a new book due out May 19, entitled "Elon Musk: Tesla, SpaceX, and the Quest for a Fantastic Future."
07:40 EDTTSLATesla March May volatility elevated into Q1 and outlook
Subscribe for More Information
07:20 EDTMACKAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
06:50 EDTTSLATesla price target slashed to $165 at JPMorgan
After lowering its earnings estimates to reflect adverse currency moves, higher operating costs and slower than earlier expected Model X ramp, JPMorgan cut its price target for Tesla shares to $165 from $175. The stock closed Friday up 9c to $206.79. The firm dropped its Q1 earnings estimate to (38c) from (31c) despite the increase in Q1 deliveries preannounced by the electric car maker. JPMorgan keeps an Underweight rating on Tesla, the firm's equivalent to a sell. It maintains Overweight ratings on Ford (F) and General Motors (GM) with price targets of $19 and $46, respectively, ahead of the Q1 reporting season.
April 17, 2015
16:11 EDTTSLAOptions Update; April 17, 2015
Subscribe for More Information
09:36 EDTTSLAActive equity options trading on open
Subscribe for More Information
April 16, 2015
06:33 EDTTSLAToyota engineer says charging electric cars quickly impractical, Reuters says
Charging electric vehicles quickly would place too much pressure on the electricity grid, Yoshikazu Tanaka, chief engineer of Toyota's hydrogen fuel-cell car Mirai, said, according to Reuters. If a car received enough electricity in 12 minutes to travel 310 miles, it would probably consume enough electricity to power 1,000 houses, the news service quoted Tanaka as saying. Prominent makers of electric cars include Tesla (TSLA), Nissan (NSANY), and GM (GM).Reference Link
April 15, 2015
09:55 EDTTSLABofA/Merrill U.S. autos analysts hold an analyst/industry conference call
Subscribe for More Information
09:35 EDTTSLAActive equity options trading on open
Subscribe for More Information
April 14, 2015
09:35 EDTTSLAActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN PBR SU NFLX ALU BIDU TSLA JNJ GE
09:17 EDTMACKMerrimack management to meet with Brean Capital
Subscribe for More Information
08:40 EDTTSLASeveral signs suggest Apple may build a car, says Bernstein
Subscribe for More Information
April 13, 2015
16:01 EDTTSLAOptions Update; April 13, 2015
Subscribe for More Information
09:34 EDTTSLAActive equity options trading on open
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use